During the past nine years, the DERC, with its Core Laboratories, Enrichment Program and support for Pilot and Feasibility. studies, has played a major role in allowing for expansion in the scope and intensity of research at the Joslin Diabetes Center and Harvard Medical School. The DERC has provided essential support for interdisciplinary studies and junior faculty, and a critical infrastructure for both basic and clinical research. It is not surprising, therefore, that over his period there has been a further strengthening of the research effort at the Joslin, a significant increase in the publications in peer-reviewed journals and a more than 50% increase in training of research fellows. Recognizing this growth in research activity and the importance of the research mission, the Joslin added three floors to its building with over 30,000 sq. ft. of additional research space, and has renovated research space in the original building, all of which has resulted in improved laboratory space for individual investigators and the DERC Core Laboratories. In this renewal application, we have attempted to build on those strengths by eliminating Core Laboratories which were underutilized (such as Flow Cytometry) and adding new Cores (such as the Computer Resource Core). In addition, we have expanded the scope of the services provided by most Cores, but especially, the Peptide Biochemistry Core, the Microscopy Core, the Radioligand Assay Laboratory for the Clinical Research Core and the Transgenic Animal Core. At the last renewal we added one Pilot and Feasibility grant to our Center for use by scientists in the Longwood area outside the Joslin and affiliated with Harvard hospitals (e.g. Harvard Medical School, Children's Hospital, Beth Israel Hospital, Brigham and Women's Hospital, Deaconess Hospital, Dana Farber Cancer Institute, Center for Blood Research and Massachusetts General Hospital), and this program will continue. Within the DERC and the Joslin we have been particularly encouraged over the past four years by the development of younger faculty who have bean supported directly and indirectly by the DERC, such as Drs. Jackson, White, Hattori, Maratos-Flier, Rhodes, Shoelson, Lipes, Goodyear and others. These individuals, along with more established investigators and new faculty recruited by virtue of expansion, create the scientific base and strength of the Joslin DERC. Finally, the strong intellectual stimulus provided by the activities of the Enrichment Program have a major impact, not only at the Joslin, but in the whole Harvard-Longwood Medical area.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK036836-11
Application #
2016186
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (08))
Program Officer
Fradkin, Judith E
Project Start
1986-09-30
Project End
2001-11-30
Budget Start
1997-02-15
Budget End
1997-11-30
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Viana-Huete, Vanesa; Guillén, Carlos; García, Gema et al. (2018) Male Brown Fat-Specific Double Knockout of IGFIR/IR: Atrophy, Mitochondrial Fission Failure, Impaired Thermogenesis, and Obesity. Endocrinology 159:323-340
Peterson, Claire M; Young-Hyman, Deborah; Fischer, Sarah et al. (2018) Examination of Psychosocial and Physiological Risk for Bulimic Symptoms in Youth With Type 1 Diabetes Transitioning to an Insulin Pump: A Pilot Study. J Pediatr Psychol 43:83-93
Rotroff, Daniel M; Pijut, Sonja S; Marvel, Skylar W et al. (2018) Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes. Clin Pharmacol Ther 103:712-721
Leitner, Brooks P; Weiner, Lauren S; Desir, Matthew et al. (2018) Kinetics of human brown adipose tissue activation and deactivation. Int J Obes (Lond) :
Commissariat, Persis V; Volkening, Lisa K; Guo, Zijing et al. (2018) Associations between major life events and adherence, glycemic control, and psychosocial characteristics in teens with type 1 diabetes. Pediatr Diabetes 19:85-91
Barbour, Linda A; Scifres, Christina; Valent, Amy M et al. (2018) A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol 219:367.e1-367.e7
Lammer, Jan; Karst, Sonja G; Lin, Michael M et al. (2018) Association of Microaneurysms on Adaptive Optics Scanning Laser Ophthalmoscopy With Surrounding Neuroretinal Pathology and Visual Function in Diabetes. Invest Ophthalmol Vis Sci 59:5633-5640
Gordin, Daniel; King, George L (2018) Response to Comment on Gordin et al. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 2018;41:815-822. Diabetes Care 41:e128
Karatepe, Kutay; Zhu, Haiyan; Zhang, Xiaoyu et al. (2018) Proteinase 3 Limits the Number of Hematopoietic Stem and Progenitor Cells in Murine Bone Marrow. Stem Cell Reports 11:1092-1105
Sustarsic, Elahu G; Ma, Tao; Lynes, Matthew D et al. (2018) Cardiolipin Synthesis in Brown and Beige Fat Mitochondria Is Essential for Systemic Energy Homeostasis. Cell Metab 28:159-174.e11

Showing the most recent 10 out of 1120 publications